P-BCMA-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Multiple Myeloma

NCT04960579 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

275

Enrollment

INDUSTRY

Sponsor class

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: P-BCMA-ALLO1 CAR-T cells
DRUG: Rimiducid
DRUG: Methotrexate

Sponsor

Poseida Therapeutics, Inc.

Collaborators

[object Object]